Neurolutions is a commercial-stage medical device company and developer of the first brain-computer interface (BCI)-controlled therapy for neurorehabilitation in stroke survivors that was awarded FDA DeNovo market authorization. THE FOUNDATION FOR COMPANY SUCCESS: ► The company’s first product candidate, the IpsiHand system, is a non-invasive technology that supports upper extremity rehabilitation for chronic stroke patients using a BCI and advanced wearable robotics.

Nile uses data science to change how we manage epilepsy care. Nile was selected to CB Insights’ Digital Health 150 as one of the most innovative digital health start-ups for 2021 in its very first year and has been featured in Bloomberg Business, Yahoo! Finance, Physicians Practice, and more. Nile raised $29.3M+ in funding to replace trying with knowing in epilepsy care. To execute this competitive company vision, the crucial first step was the development of an efficient organizational structure, experienced executive team, on and offshore operations, SOPs, an end-to-end product development process that meets ISO standards, and cross-functional business units. We are on our way to being the leader in AI-powered epilepsy care with product-market fit and out-of-the-box strategy. KEY WINS: ► Laid the foundation to shorten the path to the right treatment for epilepsy patients through the development of an FDA-registered SAMD, with a healthcare provider dashboard and patient-facing Android and iOS app. ► Quality and regulatory compliance by achieving ISO 13485 certification for medical device design and production within 11 months of launch. ► Strategic business development resulted in multiple deals with major hospital systems across the U.S. within 3 months of product launch. ► Surpassed the 90-day goal for Nile app downloads by 350% with a 4.5/5 app rating. ► The Epilepsy Foundation selected Nile as their preferred Diary App for epilepsy patients.

NovaSignal (formerly Neural Analytics, Inc.) is commercializing fully-autonomous ultrasound imaging systems, substituting an autonomous robot for the technician and artificial intelligence algorithms for the physician. KEY ACHIEVEMENTS: ► Long-term strategic vision, fast-tracking milestone achievement, and operational efficiency. ► Financial support by securing $75M+ in venture financing and $20M in government contracts and grants. ► World-class executives to complement the founding team, scaling the workforce from 3 co-founders to 120 employees. ► Optimized product development, market development, and the supply chain forging strategic public and private corporate partnerships. ► Accelerated product launches and sales cycles by teaming with stakeholders to strategize a product portfolio with significant intrinsic demand. ► Rapid product optimization and regulatory clearance through the build of an ISO 13485-compliant manufacturing facility collocated with product development. ► Attaining first regulatory clearance in year 3 after only a $10M investment and the second in year 5 (FDA and CE clearance). ► Significant sustainable growth, producing 100+ intellectual property assets to secure market position. 80+ scientific/publications to drive market adoption.

Custom Nanotech is an early-stage technology partner for University-originated intellectual property, translating academic nanotechnology research into product strategies and transferring technology to mass production. RESULTS: ► Development of specialized electronics, and pilot prototype production to secure seed funding. ► Company revenue from customer partnership agreements grew to $500K+. ► To date, the team has co-authored 12 patents issued or pending for nanofabrication and nano-device design.

Nabsys is the pioneer in electronic whole-genome mapping and the creator of the patented HD-Mapping platform that leverages high-resolution, high-speed nanodetectors. ACHIEVEMENTS: ► $25M+ in private investor funding due to its compelling technology commercialization plan for device production. ► Invention of the biosensor as the core of the company’s patented technology. Secured intellectual property rights that enable future product development. ► Pilot production by scaling technology from Harvard, Brown, and Cornell Universities to a commercial semiconductor foundry.